里瓦斯蒂格作为一种替代品,用于治疗抗胆固醇毒性治疗的索斯蒂格缺乏症
Omid Mehrpour1, Mario Marini2, Samaneh Nakhaee3
1Medical Toxicology LLC, Tucson, AZ, USA; Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
Regulatory toxicology and pharmacology : RTP
|May 25, 2025
概括
抗胆固醇毒性需要及时治疗. 研究人员探索了一种胆酶抑制剂的利瓦斯蒂格明,作为一种潜在的替代品,因为它有能力穿越血脑屏障.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 抗胆固醇毒性呈现出严重的症状,如狂妄和心率低下,需要紧急医疗干预.
- 胆化酶抑制剂菲索斯蒂格是标准治疗方法,但偶尔面临可用性问题.
- 需要替代治疗的原因是索斯蒂格因稀缺.
研究的目的:
- 评估使用里瓦斯蒂格明作为抗胆固醇毒性的替代治疗方法的可行性.
- 评估瑞瓦斯蒂格明能够穿透血脑屏障 (BBB) 的能力.
- 为了确定里瓦斯蒂格明在控制抗胆固醇毒性毒性症状方面的疗效.
主要方法:
- 文献综述,重点关注胆酶抑制剂及其特性.
- 分析里瓦斯蒂格明的药理动力学概况,特别是其BBB透率.
- 检查案例研究或临床前数据,以检查rivastigmine在抗胆固醇毒性的使用情况.
主要成果:
- 里瓦斯蒂格,就像菲索斯蒂格一样,是一种可逆胆酶抑制剂.
- 有证据表明,里瓦斯蒂格明具有允许BBB透的特性.
- 初步数据表明,在减轻抗胆性症状方面具有潜在的有效性.
结论:
- 里瓦斯蒂格明显示承诺作为一个可行的替代品来治疗抗胆固醇毒性治疗physostigmine.
- 需要进一步的临床研究来证实里瓦斯蒂格明的安全性和有效性.
- 解决索斯蒂格稀缺问题可能涉及到探索和验证像利瓦斯蒂格这样的药物.
相关概念视频
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
863
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
863
01:26Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K
01:26Cholinergic Antagonists: Therapeutic Uses
894
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
894
01:24Parkinson's Disease: Treatment
394
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
394
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
669
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
669